Xie L Xu Selected Research

Xie L Xu Research Topics

15	Psoriatic Arthritis 11/2022 - 01/2018
6	Infections 01/2022 - 01/2018
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2018
2	Fatigue 11/2022 - 01/2022
2	Opportunistic Infections (Opportunistic Infection) 12/2021 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2021
2	Neoplasms (Cancer) 12/2021 - 02/2009
2	Necrosis 01/2021 - 01/2018
2	Pruritus (Itching) 02/2015 - 07/2014
1	Pain (Aches) 11/2022
1	Arthritis (Polyarthritis) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Tuberculosis (Tuberculoses) 12/2021
1	Uveitis 12/2021
1	Injection Site Reaction 12/2021
1	Heart Failure 01/2020
1	Rheumatoid Arthritis 01/2016
1	Agranulocytosis (Granulocytopenia) 02/2015
1	Neutropenia 02/2015
1	Nausea 07/2014
1	Headache (Headaches) 07/2014
1	Glioma (Gliomas) 02/2009
1	Glioblastoma (Glioblastoma Multiforme) 02/2009

15	guselkumabIBA 11/2022 - 01/2018
7	Monoclonal AntibodiesIBA 08/2022 - 01/2018
5	Biological ProductsIBA 01/2022 - 01/2020
5	Interleukin-23 (Interleukin 23)IBA 01/2022 - 01/2018
4	C-Reactive ProteinIBA 01/2021 - 01/2020
3	InterleukinsIBA 01/2022 - 01/2018
3	Immunoglobulin A (IgA)IBA 01/2022 - 02/2015
3	Interleukin-23 Subunit p19IBA 01/2021 - 01/2020
2	CollagenIBA 08/2022 - 08/2022
2	Biomarkers (Surrogate Marker)IBA 08/2022 - 08/2022
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2020
2	Histamine H4 ReceptorsIBA 01/2016 - 07/2014
2	4- (3- aminopyrrolidin- 1- yl)- 6- isopropylpyrimidin- 2- ylamineIBA 02/2015 - 07/2014
1	AntibodiesIBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	apremilastIBA 01/2020
1	CytokinesIBA 01/2020
1	Tumor Necrosis Factor InhibitorsIBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	toreforantIBA 01/2016
1	Pharmaceutical PreparationsIBA 02/2015
1	Cetirizine (Zyrtec)FDA LinkGeneric 07/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2009

5	Therapeutics 01/2022 - 02/2009